Type 2 Diabetes Exemplar: A Remote Care Service for North West London

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 235 participants.

Also called NCT04731142

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 235 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04731142
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04731142. Non-randomized; no masking; primary purpose treatment. Start 2021-06-01 (actual); primary completion 2022-06-30 (actual). Results posted on 2024-02-20.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Type 2 Diabetes Exemplar: A Remote Care Service for North West London
Acronym
T2DEx
Condition
Type 2 Diabetes Mellitus
Intervention (Device)
Huma
Intervention (Behavioral)
Video group consultations
Intervention (Behavioral)
KNOW Diabetes
Intervention (Other)
Standard of care
Lead sponsor
Imperial College London (class: other)
Collaborator
AstraZeneca (class: industry)
Collaborator
Huma (class: industry)
Collaborator
North West London Collaboration of CCGs (NWL CCGs) (class: other)
Collaborator
Imperial College Health Partners (ICHP) (class: other)

Record details

Record id
cardio:ct-nct04731142
Content hash
3a6ddbbf8349b21534eaebca440ddb7616e3ef8469ab55ab7959feedcc77f4ba